SCHEMBL23094183

SCHEMBL23094183

COc1ccccc1C/C(N)=N/OC(=O)COc1cc(C)c(Cl)c(C)c1

nearest known ligand 0.73

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 5/20 0.73
▸ HTT P42858 1/20 0.73
▸ TDP1 Q9NUW8 9/20 0.72
▸ L3MBTL1 Q9Y468 7/20 0.72
▸ SMN1; SMN2 Q16637 1/20 0.72
▸ MAPK1 P28482 3/20 0.69
▸ ALDH1A1 P00352 1/20 0.62
▸ HPGD P15428 1/20 0.62
▸ LMNA P02545 1/20 0.61
▸ CYP1A2 P05177 2/20 0.54
▸ CYP3A4 P08684 2/20 0.54
▸ CYP2C19 P33261 2/20 0.54
▸ KDM4E B2RXH2 1/20 0.54
▸ CYP2D6 P10635 1/20 0.50
▸ MEN1 O00255 1/20 0.49
▸ POLB P06746 1/20 0.49
▸ RECQL P46063 1/20 0.49
▸ KMT2A Q03164 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23094250 0.86 MAPT (0.81) MAPTHTTTDP1L3MBTL1SMN1; SMN2
SCHEMBL23094264 0.85 MAPT (0.74) MAPTHTTTDP1L3MBTL1SMN1; SMN2
SCHEMBL2182563 0.84 MAPT (1.00) MAPTHTTTDP1L3MBTL1SMN1; SMN2
SCHEMBL2182559 0.84 MAPT (1.00) MAPTHTTTDP1L3MBTL1SMN1; SMN2
SCHEMBL23094164 0.84 TDP1 (1.00) MAPTHTTTDP1L3MBTL1SMN1; SMN2
SCHEMBL21467841 0.84 L3MBTL1 (1.00) MAPTHTTTDP1L3MBTL1SMN1; SMN2
SCHEMBL4302439 0.84 MAPT (0.61) MAPTHTTTDP1L3MBTL1SMN1; SMN2
SCHEMBL4302442 0.84 MAPT (0.61) MAPTHTTTDP1L3MBTL1SMN1; SMN2
SCHEMBL23094234 0.83 MAPT (0.76) MAPTHTTTDP1L3MBTL1SMN1; SMN2
SCHEMBL23094202 0.82 TDP1 (0.81) MAPTHTTTDP1L3MBTL1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10947188-B2 Small molecule ferroptosis inducers THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2021-03-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10947188-B2 Small molecule ferroptosis inducers GPX4, AIFM2, GPX1 MAPT 4344/4885HTT 3066/4885TDP1 4664/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback